Birgit Jaschke

Randomized Trial of a Nonpolymer-Based Rapamycin-Eluting Stent Versus a Polymer-Based Paclitaxel-Eluting Stent for the Reduction of Late Lumen Loss

Julinda Mehilli, Adnan Kastrati, Rainer Wessely et al. · Circulation · 2006 · 178 citations

Inhibition of Neointima Formation by a Novel Drug-Eluting Stent System That Allows for Dose-Adjustable, Multiple, and On-Site Stent Coating

Rainer Wessely, Jörg Hausleiter, Cornelia Michaelis et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 131 citations · Full text

Targeting 2A Protease by RNA Interference Attenuates Coxsackieviral Cytopathogenicity and Promotes Survival in Highly Susceptible Mice

Sabine Merl, Cornelia Michaelis, Birgit Jaschke et al. · Circulation · 2005 · 67 citations · Full text

Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform

Birgit Jaschke, Christiane Michaelis, Stefan Milz et al. · Cardiovascular Research · 2005 · 62 citations

Local cyclin‐dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug‐ eluting stents to prevent neointima formation following vascular injury

Birgit Jaschke, Stefan Milz, Michael Vogeser et al. · The FASEB Journal · 2004 · 23 citations

Vascular Disease, Cardiovascular Pharmacology, Cell Death +21